Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease

PVRI Member Authors: Christoph Wiedenroth, Karen Olsson


Symptomatic patients with residual pulmonary perfusion defects or vascular lesions but no pulmonary hypertension at rest are diagnosed with chronic thromboembolic disease (CTED). Balloon pulmonary angioplasty (BPA) is an emerging treatment for patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH), but data regarding the safety and efficacy of BPA in patients with CTED are lacking. We report a prospective series of ten consecutive patients with CTED who underwent 35 BPA interventions (median of four per patient) at two German institutions. All patients underwent a comprehensive diagnostic workup at baseline and 24 weeks after their last intervention. . . . .

Read the full article online


Pulmonary Hypertension


Stefan Guth, Andreas Breithecker, Moritz Haas, Jan-Christopher Kamp, Jan Fuge, Jan B. Hinrichs, Fritz Roller, Christian W. Hamm, Eckhard Mayer, Hossein A. Ghofrani, Bernhard C. Meyer, Christoph Liebetrau

Published in:

Pulmonary Circulation Vol 8: No 1 cover image

March 2018

Pulmonary Circulation Vol 8: No 1

View this journal

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI